Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 469 to 470 of 470 entries
Sorted by: Best Match Show Resources per page
Hepatitis B Virus/Hepatitis D Virus-Coinfected Liver Transplant Candidate Receiving Hepatitis B Virus-Deoxyribonucleic Acid-Positive Allograft and Treated With High-Dose Hepatitis B Immune Globulin.

ACG case reports journal

Hammami MB, Kohli R, Woreta T, Sulkowski MS, Hamilton JP, Toman L, Saberi B, Laurin J, Wang JG, Philosophe B, Cameron AM, Gurakar A.
PMID: 34549060
ACG Case Rep J. 2021 May 12;8(5):e00582. doi: 10.14309/crj.0000000000000582. eCollection 2021 May.

Liver transplantation (LT) for patients with hepatitis D virus (HDV) and hepatitis B virus (HBV) coinfection is uncommon in the United States. Previous case reports described poor outcomes when hepatitis B surface antigen (HBsAg)-positive grafts are transplanted in HBV/HDV-coinfected...

Cite
Hammami MB, Kohli R, Woreta T, et al. Hepatitis B Virus/Hepatitis D Virus-Coinfected Liver Transplant Candidate Receiving Hepatitis B Virus-Deoxyribonucleic Acid-Positive Allograft and Treated With High-Dose Hepatitis B Immune Globulin. ACG Case Rep J. 2021;8(5):e00582doi: 10.14309/crj.0000000000000582.
Hammami, M. B., Kohli, R., Woreta, T., Sulkowski, M. S., Hamilton, J. P., Toman, L., Saberi, B., Laurin, J., Wang, J. G., Philosophe, B., Cameron, A. M., & Gurakar, A. (2021). Hepatitis B Virus/Hepatitis D Virus-Coinfected Liver Transplant Candidate Receiving Hepatitis B Virus-Deoxyribonucleic Acid-Positive Allograft and Treated With High-Dose Hepatitis B Immune Globulin. ACG case reports journal, 8(5), e00582. https://doi.org/10.14309/crj.0000000000000582
Hammami, Muhammad Baraa, et al. "Hepatitis B Virus/Hepatitis D Virus-Coinfected Liver Transplant Candidate Receiving Hepatitis B Virus-Deoxyribonucleic Acid-Positive Allograft and Treated With High-Dose Hepatitis B Immune Globulin." ACG case reports journal vol. 8,5 (2021): e00582. doi: https://doi.org/10.14309/crj.0000000000000582
Hammami MB, Kohli R, Woreta T, Sulkowski MS, Hamilton JP, Toman L, Saberi B, Laurin J, Wang JG, Philosophe B, Cameron AM, Gurakar A. Hepatitis B Virus/Hepatitis D Virus-Coinfected Liver Transplant Candidate Receiving Hepatitis B Virus-Deoxyribonucleic Acid-Positive Allograft and Treated With High-Dose Hepatitis B Immune Globulin. ACG Case Rep J. 2021 May 12;8(5):e00582. doi: 10.14309/crj.0000000000000582. eCollection 2021 May. PMID: 34549060; PMCID: PMC8443809.
Copy Download .nbib Format: NLM
Evaluation of Early vs Standard Liver Transplant for Alcohol-Associated Liver Disease.

JAMA surgery

Herrick-Reynolds KM, Punchhi G, Greenberg RS, Strauss AT, Boyarsky BJ, Weeks-Groh SR, Krach MR, Anders RA, Gurakar A, Chen PH, Segev DL, King EA, Philosophe B, Ottman SE, Wesson RN, Garonzik-Wang JM, Cameron AM.
PMID: 34379106
JAMA Surg. 2021 Nov 01;156(11):1026-1034. doi: 10.1001/jamasurg.2021.3748.

IMPORTANCE: Traditionally, liver transplant (LT) for alcohol-associated liver disease (ALD) requires 6 months of abstinence. Although early LT before 6 months of abstinence has been associated with decreased mortality for decompensated ALD, this practice remains controversial and concentrated at...

Cite
Herrick-Reynolds KM, Punchhi G, Greenberg RS, et al. Evaluation of Early vs Standard Liver Transplant for Alcohol-Associated Liver Disease. JAMA Surg. 2021;156(11):1026-1034doi: 10.1001/jamasurg.2021.3748.
Herrick-Reynolds, K. M., Punchhi, G., Greenberg, R. S., Strauss, A. T., Boyarsky, B. J., Weeks-Groh, S. R., Krach, M. R., Anders, R. A., Gurakar, A., Chen, P. H., Segev, D. L., King, E. A., Philosophe, B., Ottman, S. E., Wesson, R. N., Garonzik-Wang, J. M., & Cameron, A. M. (2021). Evaluation of Early vs Standard Liver Transplant for Alcohol-Associated Liver Disease. JAMA surgery, 156(11), 1026-1034. https://doi.org/10.1001/jamasurg.2021.3748
Herrick-Reynolds, Kayleigh M, et al. "Evaluation of Early vs Standard Liver Transplant for Alcohol-Associated Liver Disease." JAMA surgery vol. 156,11 (2021): 1026-1034. doi: https://doi.org/10.1001/jamasurg.2021.3748
Herrick-Reynolds KM, Punchhi G, Greenberg RS, Strauss AT, Boyarsky BJ, Weeks-Groh SR, Krach MR, Anders RA, Gurakar A, Chen PH, Segev DL, King EA, Philosophe B, Ottman SE, Wesson RN, Garonzik-Wang JM, Cameron AM. Evaluation of Early vs Standard Liver Transplant for Alcohol-Associated Liver Disease. JAMA Surg. 2021 Nov 01;156(11):1026-1034. doi: 10.1001/jamasurg.2021.3748. PMID: 34379106; PMCID: PMC8358815.
Copy Download .nbib Format: NLM
Showing 469 to 470 of 470 entries